JPH0510969B2 - - Google Patents

Info

Publication number
JPH0510969B2
JPH0510969B2 JP60170627A JP17062785A JPH0510969B2 JP H0510969 B2 JPH0510969 B2 JP H0510969B2 JP 60170627 A JP60170627 A JP 60170627A JP 17062785 A JP17062785 A JP 17062785A JP H0510969 B2 JPH0510969 B2 JP H0510969B2
Authority
JP
Japan
Prior art keywords
acid
salt
pentadecanolide
dicarboxy
value
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60170627A
Other languages
Japanese (ja)
Other versions
JPS6230546A (en
Inventor
Yutaka Ishigami
Yoshitaka Uji
Katsunobu Masui
Juji Shibayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institute of Advanced Industrial Science and Technology AIST
Original Assignee
Agency of Industrial Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency of Industrial Science and Technology filed Critical Agency of Industrial Science and Technology
Priority to JP60170627A priority Critical patent/JPS6230546A/en
Publication of JPS6230546A publication Critical patent/JPS6230546A/en
Publication of JPH0510969B2 publication Critical patent/JPH0510969B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Colloid Chemistry (AREA)
  • Detergent Compositions (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

〔産業上の利用分野〕 この発明は、化粧品、医薬品、医薬部外品、ト
イレタリー用品等の各種産業分野において広く利
用される多塩基酸型バイオサーフアクタント系乳
化組成物に関するものである。 〔従来の技術〕 近年、乳化に関連して数多くの研究がなされ、
新規の乳化剤および乳化技術の進歩は著しく、安
定性の非常によいエマルジヨンが各種産業分野で
広く利用されるようになつた。しかしその多くは
非イオン界面活性剤、陰イオン界面活性剤、陽イ
オン界面活性剤、または両性界面活性剤を乳化剤
としたものであつて、一般消費者の間では安全性
の面でかなりの不安感を持つ人が多い。また、比
較的安全性が高く使用感も良好である高級脂肪酸
石けんを乳化剤とするものが従来から使用されて
来たが、石けん本来の性質上乳化組成物のPH値は
7.0以上の弱アルカリ性であつて、皮膚刺激など
の問題があり、また皮膚に塗布したとき起泡性が
大きく、いつまでも白さが消滅しないので使用上
好ましくない。さらに、非イオン界面活性剤のみ
で乳化を行なつたときにはクリーミング等の面で
問題があり、石けん系の乳化剤との併用が望まし
い。 〔発明が解決しようとする問題点〕 このように、従来の乳化剤には安全性を始めと
し、エマルジヨンの安定性、使用感などの諸物性
に解決すべき多くの問題点があつた。 〔問題を解決するための手段〕 上記の問題点を解決するために、この発明は油
相成分に4,5−ジカルボキシ−4−ペンタデカ
ノリド(スピクリスポール酸)、4,5−ジカル
ボキシ−4−ペンタデカノリドの塩、4,5−ジ
カルボキシ−4−ペンタデカノリドのラクトン環
を開環した3−ヒドロキシ−1,3,4−テトラ
デカントリカルボン酸またはその塩の4成分のう
ちの少なくとも1成分を添加し、PH値を7.0以下
に調整してなる多塩基酸型バイオサーフアクタン
ト系乳化組成物とする手段を採用するものであ
る。以下その詳細を述べる。 まず、この発明における4,5−ジカルボキシ
−4−ペンタデカノリド(スピクリスポール酸)
はブドウ糖を原料とする微生物工業プロセスによ
つてペニシリウム・スピクリスポラムの代謝産物
として高収率で量産される物質であり、構成式 で示される。以下この4,5−ジカルボキシ−4
−ペンタデカノリド(スピクリスポール酸)をS
酸と略記する。 このようなS酸は融点143〜146℃、比旋光度
(c=3.28g/dl、エタノール)〔α〕26 D=−12.6、
酸価338.2、ケン化価508.0、ヨウ素価0.5以下のも
のである。 つぎにこの発明の3−ヒドロキシ−1,3,4
−テトラデカントリカルボン酸(以下これをO酸
と略記する)は前記S酸に計算量よりも過剰の水
酸化ナトリウム水溶液を加えて加熱した後酸で中
和すれば得られる物質でありS酸のラクトン環が
開環した構造式 で示される。 このようなS酸およびO酸のそれぞれの塩を形
成するには、水酸化ナトリウム、水酸化カリウ
ム、水酸化リチウム、水酸化セシウム、水酸化ア
ンモニウム、水酸化カルシウム、水酸化マグネシ
ウムなどの無機塩基、リチウムイオン、ナトリウ
ムイオン、カリウムイオン、アンモニウムイオ
ン、カルシウムイオン、マグネシウムイオンを含
む塩基性無機塩および塩基性有機塩、リジン、ア
ルギニン、ヒスチジン、オルニチンなどの塩基性
アミノ酸およびそれらを塩基として有する塩基性
オリゴペプチド、モノエタノールアミン、ジエタ
ノールアミン、トリエタノールアミンなどの塩基
性アミン等が用いられるが、それぞれの塩は予め
アルコールでケン化もしくは中和し塩にしたもの
であつても、また、乳化組成物の製造工程中に反
応生成される塩であつてもよい。なお、S酸およ
びO酸は水のみではケン化もしくは中和が困難で
あるため、アルコールが併用されるが、この際使
用されるアルコールを例としては、メタノール、
エタノール、プロパノール、ブタノールなどの一
価アルコール、エチレングリコール、プロピレン
グリコール、1,3−ブチレングリコール、1,
4−ブチレングリコール、ヘキシレングリコー
ル、ジエチレングリコール、ジプロピレングリコ
ールもしくはそれ以上のポリアルキレングリコー
ル、またはグリセリン、ジグリセリン、トリグリ
セリンもしくはそれ以上のポリグリセリン、さら
にグルコース、マルトース、マルチトール、シヨ
糖、ソルビトールなどの分子内に2個以上の水酸
基を有する多価アルコールなどを拳げることがで
き、これらの群から選ばれる1種または2種以上
の混合物であれば特に限定されるものではない
が、実質的には分子内に2個以上の水酸基を有す
る多価アルコールが利用される。あ したがつ
て、多価アルコール中でS酸およびO酸をアルカ
リでケン化もしくは中和を行ない、これに油相成
分を加え、さらに必要ならば水相成分を加えて乳
化組成物を調製することができるが、このような
方法は最近着目されている多価アルコール中油型
の乳化方法であり、この発明の多塩基酸型バイオ
サーフアクタント系乳化組成物を得るにはきわめ
て都合のよい方法である。なお、この発明の乳化
組成物は皮膚に対する生理的安全性の面から、PH
値を7.0以下とするために、S酸およびO酸をケ
ン化もしくは中和に使用する塩基の量を予め調整
するか、または過剰の塩基を酸で中和するかし
て、所望のPH値に整えることが必要となる。 いま、S酸を水酸化ナトリウムで中和するとき
の滴定曲線はたとえば第1図および第2図のとお
りである。第1図はS酸0.200gを0.1Nの水酸化
ナトリウム水溶液で部分的に中和した後、これを
蒸留水で50mlに希釈し、0.1Nの水酸化ナトリウ
ム水溶液で滴定したときの滴定量とPH値の関係
を、また第2図はS酸0.200gをエタノール水溶
液(4:1)で溶解し、これを蒸留水で50mlに希
釈し、0.1Nの水酸化ナトリウム水溶液で滴定し
たときの滴定量とPH値との関係をそれぞれ示した
ものである。さらに、S酸およびO酸のナトリウ
ム塩の濃度(mol/)と30℃における表面張力
dyn/cm)との関係を示せば第3図のとおりであ
る。すなわち、O酸の一ナトリウム塩(O−1Na
と略記する)の臨界ミセル濃度は3.6×10-3M、
0.133%で、臨界セミル濃度における表面張力cnc
は38dyn/cmであり、臨界セミル濃度8×
10-3M、0.24%のラウリル硫酸ナトリウムと同等
の界面活性を示し、S酸の一ナトリウム塩(S−
1Na)の臨界ミセル濃度は3.9×10-3M、0.14%と
前記O−1Naよりやや高く、、表面張力cnc
32dyn/cmである。分子の表面占有面積はO−
1Naで96.0Å2、S−1Naで98.8Å2と両者ほぼ同
じであるが、1分子の表面占有面積が52Å2であ
る前記ラウリル硫酸ナトリウムよりは遥かに大き
い値で嵩高いことを示している。したがつて、S
酸およびO酸のナトリウム塩はラウリル硫酸ナト
リウムに匹敵する界面活性を有する脂肪酸石けん
型の乳化剤であることが明らかである。 つぎに、S酸のナトリウム塩の起泡力(泡容積
mlの経時変化)をラウリル硫酸ナトリウムのそれ
と比較すると第1表から明らかなように、S酸
[Industrial Application Field] The present invention relates to a polybasic acid type biosurfactant emulsion composition that is widely used in various industrial fields such as cosmetics, pharmaceuticals, quasi-drugs, and toiletry products. [Prior art] In recent years, a large number of studies have been conducted related to emulsification.
New emulsifiers and emulsification technology have made remarkable progress, and highly stable emulsions have come to be widely used in various industrial fields. However, most of them use nonionic surfactants, anionic surfactants, cationic surfactants, or amphoteric surfactants as emulsifiers, and general consumers are concerned about their safety. Many people feel that way. In addition, higher fatty acid soaps, which are relatively safe and have a good feel when used, have been used as emulsifiers, but due to the inherent properties of soaps, the PH value of emulsified compositions is low.
It is weakly alkaline with a value of 7.0 or higher, which causes problems such as skin irritation, and when applied to the skin, it has a large foaming property and the whiteness does not disappear forever, making it undesirable for use. Furthermore, when emulsifying with only a nonionic surfactant, there are problems in terms of creaming, etc., so it is desirable to use a soap-based emulsifier in combination. [Problems to be Solved by the Invention] As described above, conventional emulsifiers have had many problems that need to be solved, including safety, as well as various physical properties such as emulsion stability and usability. [Means for Solving the Problems] In order to solve the above problems, the present invention includes 4,5-dicarboxy-4-pentadecanolide (spicrisporic acid) and 4,5-dicarboxy-4-pentadecanolide as oil phase components. - Adding at least one component of the following four components: a salt of pentadecanolide, 3-hydroxy-1,3,4-tetradecanetricarboxylic acid ring-opened with the lactone ring of 4,5-dicarboxy-4-pentadecanolide, or a salt thereof; This method adopts a method of preparing a polybasic acid type biosurfactant emulsion composition by adjusting the pH value to 7.0 or less. The details will be described below. First, 4,5-dicarboxy-4-pentadecanolide (spicrisporic acid) in this invention
is a substance that is mass-produced in high yield as a metabolite of Penicillium spicrisporum through a microbial industrial process using glucose as a raw material, and has the constitutive formula: It is indicated by. Below, this 4,5-dicarboxy-4
-S pentadecanolide (spicrisporic acid)
Abbreviated as acid. Such an S acid has a melting point of 143-146°C, a specific optical rotation (c = 3.28 g/dl, ethanol) [α] 26 D = -12.6,
It has an acid value of 338.2, a saponification value of 508.0, and an iodine value of 0.5 or less. Next, 3-hydroxy-1,3,4 of this invention
-Tetradecanetricarboxylic acid (hereinafter abbreviated as O acid) is a substance obtained by adding an excess of sodium hydroxide aqueous solution than the calculated amount to the S acid, heating it, and neutralizing it with acid, and it is a lactone of S acid. Structural formula with open ring It is indicated by. To form the respective salts of such S and O acids, an inorganic base such as sodium hydroxide, potassium hydroxide, lithium hydroxide, cesium hydroxide, ammonium hydroxide, calcium hydroxide, magnesium hydroxide; Basic inorganic salts and basic organic salts containing lithium ions, sodium ions, potassium ions, ammonium ions, calcium ions, and magnesium ions, basic amino acids such as lysine, arginine, histidine, ornithine, and basic oligos having these as bases. Peptides, basic amines such as monoethanolamine, diethanolamine, triethanolamine, etc. are used, but each salt may be saponified or neutralized with alcohol in advance to form a salt; It may also be a salt produced by reaction during the manufacturing process. Note that it is difficult to saponify or neutralize S acid and O acid with water alone, so alcohol is used in combination. Examples of alcohols used in this case include methanol,
Monohydric alcohols such as ethanol, propanol, butanol, ethylene glycol, propylene glycol, 1,3-butylene glycol, 1,
4-butylene glycol, hexylene glycol, diethylene glycol, dipropylene glycol or higher polyalkylene glycols, or glycerin, diglycerin, triglycerin or higher polyglycerols, as well as glucose, maltose, maltitol, sucrose, sorbitol, etc. Polyhydric alcohols having two or more hydroxyl groups in the molecule are not particularly limited as long as they are one or a mixture of two or more selected from these groups. Specifically, polyhydric alcohols having two or more hydroxyl groups in the molecule are used. Therefore, the S acid and the O acid are saponified or neutralized with an alkali in a polyhydric alcohol, and an oil phase component is added thereto, and if necessary, an aqueous phase component is added to prepare an emulsified composition. However, such a method is an oil-in-polyhydric alcohol emulsification method that has recently attracted attention, and is an extremely convenient method for obtaining the polybasic acid type biosurfactant emulsion composition of the present invention. It is. In addition, the emulsified composition of this invention has a PH of
In order to keep the value below 7.0, the amount of base used to saponify or neutralize the S acid and O acid is adjusted in advance, or the excess base is neutralized with acid to achieve the desired PH value. It is necessary to arrange it. Now, the titration curve when S acid is neutralized with sodium hydroxide is shown in FIGS. 1 and 2, for example. Figure 1 shows the titer when 0.200g of S acid is partially neutralized with 0.1N aqueous sodium hydroxide solution, diluted to 50ml with distilled water, and titrated with 0.1N aqueous sodium hydroxide solution. Figure 2 shows the relationship between PH values and the titration when 0.200 g of S acid is dissolved in an aqueous ethanol solution (4:1), diluted to 50 ml with distilled water, and titrated with a 0.1N aqueous sodium hydroxide solution. The relationship between the amount and the PH value is shown. Furthermore, the concentration (mol/) of sodium salts of S acid and O acid and the surface tension at 30 °C
dyn/cm) is shown in Figure 3. That is, the monosodium salt of O acid (O-1Na
) has a critical micelle concentration of 3.6×10 -3 M,
Surface tension cnc at critical cemil concentration at 0.133%
is 38dyn/cm, and the critical cemil concentration is 8×
10 -3 M, 0.24% sodium lauryl sulfate, and has a surface activity similar to that of the monosodium salt of S acid (S-
The critical micelle concentration of 1Na) is 3.9×10 -3 M, 0.14%, which is slightly higher than the above O-1Na, and the surface tension cnc is
It is 32dyn/cm. The surface area occupied by the molecule is O-
96.0 Å 2 for 1Na and 98.8 Å 2 for S-1Na, which are almost the same, but the surface area of one molecule is much larger than that of sodium lauryl sulfate, which is 52 Å 2 , indicating that it is bulky. . Therefore, S
It appears that the sodium salts of acids and O-acids are fatty acid soap-type emulsifiers with surface activities comparable to sodium lauryl sulfate. Next, the foaming power (foam volume
ml over time) with that of sodium lauryl sulfate, it is clear from Table 1 that S acid

〔実施例〕〔Example〕

実施例 1 油相成分としてスクワラン10部(重量部、以下
同じ)、ミリスチン酸オクチルドデシル15部、セ
タノール2部を75℃において溶解したもの(B相
と呼ぶ)を、スピクリスポール酸の一カリウム塩
1部とグリセリン20部とを75℃において加熱溶解
させた液(A相と呼ぶ)に撹拌しながら加え、さ
らにこれをホモミキサーで充分に混合し、水相成
分として75℃の精製水52部(C相と呼ぶ)を加
え、これを40℃まで撹拌冷却して乳化組成物を得
た。得られた乳化組成物の状態を観察し、25℃に
おけるPH値および粘度(cp)、粒子径(μm)と
45℃7日後の乳化安定性を求め第2表にまとめ
た。
Example 1 A solution of 10 parts of squalane (parts by weight, same hereinafter), 15 parts of octyldodecyl myristate, and 2 parts of cetanol as oil phase components at 75°C (referred to as phase B) was mixed with monopotassium salt of spicrysporic acid. 1 part of glycerin and 20 parts of glycerin were heated and dissolved at 75°C (referred to as phase A) and added with stirring, and this was thoroughly mixed with a homomixer to form 52 parts of purified water at 75°C as an aqueous phase component. (referred to as phase C) was added thereto, and the mixture was stirred and cooled to 40°C to obtain an emulsified composition. Observe the state of the obtained emulsified composition and check the PH value, viscosity (cp), and particle size (μm) at 25°C.
The emulsion stability after 7 days at 45°C was determined and summarized in Table 2.

〔効果〕〔effect〕

以上述べたこの発明の多塩基酸型バイオサーフ
アクタント系乳化組成物は、従来の石けん乳化剤
のなし得なかつた酸性領域で乳化されたものであ
るから、皮膚生理上の安全性を高め、消費者の不
安を招くことなく、安全性がきわめて高く安定性
の優れた乳化組成物であることが明らかである。
また、多塩基型バイオソープの界面活性はラウリ
ル硫酸ナトリウムと同程度であるにも拘らず、起
泡性は低く乳化組成物を皮膚に塗布したとき、従
来の石けん乳化剤のように白くならず使用感はき
わめて優れている。さらに合成界面活性剤と異な
つて生分解性も良好であるので、この発明の乳化
組成物の意義はきわめて大きいと言うことができ
る。
The polybasic acid type biosurfactant emulsion composition of the present invention described above is emulsified in an acidic region that cannot be achieved with conventional soap emulsifiers, so it has improved skin physiological safety and is suitable for consumption. It is clear that the emulsion composition is extremely safe and has excellent stability, without causing anxiety among people.
In addition, although the surface activity of polybasic biosoap is comparable to that of sodium lauryl sulfate, its foaming properties are low and when the emulsified composition is applied to the skin, it does not turn white like conventional soap emulsifiers. The feel is extremely good. Furthermore, unlike synthetic surfactants, it has good biodegradability, so it can be said that the emulsified composition of the present invention is extremely significant.

【図面の簡単な説明】[Brief explanation of drawings]

第1図および第2図はスピクリスポール酸を
0.1Nの水酸化ナトリウム水溶液で滴定したとき
の滴定量とPH値との関係(第1図はスピクリスポ
ール酸の希釈液が蒸留水のみ、第2図は希釈液が
エタノール水溶液の場合)を示し、第3図はスピ
クリスポール酸のナトリウム塩および3−ヒドロ
キシ−1、3、4−テトラデカントリカルボン酸
のナトリウム塩の濃度と表面張力との関係を示す
図である。 S……スピクリスポール酸、O……3−ヒドロ
キシ−1、3、4−テトラデカントリカルボン
酸、1Na……一ナトリウム塩、2Na……二ナトリ
ウム塩、3Na……三ナトリウム塩。
Figures 1 and 2 show spicrisporic acid.
The relationship between the titration amount and PH value when titrated with a 0.1N aqueous sodium hydroxide solution (Figure 1 shows the case where the diluent of spicrisporic acid is distilled water only, and Figure 2 shows the case where the diluent is an ethanol aqueous solution). , FIG. 3 is a diagram showing the relationship between the concentration and surface tension of the sodium salt of spicrisporic acid and the sodium salt of 3-hydroxy-1,3,4-tetradecanetricarboxylic acid. S...spicrisporic acid, O...3-hydroxy-1,3,4-tetradecanetricarboxylic acid, 1Na...monosodium salt, 2Na...disodium salt, 3Na...trisodium salt.

Claims (1)

【特許請求の範囲】[Claims] 1 油相成分に、4,5−ジカルボキシ−4−ペ
ンタデカノリド(スピクリスポール酸)、4,5
−ジカルボキシ−4−ペンタデカノリドの塩、
4,5−ジカルボキシ−4−ペンタデカノリドの
ラクトン環を開環した3−ヒドロキシ−1,3,
4−テトラデカントリカルボン酸またはその塩の
4成分のうちの少なくとも1成分を添加し、PH値
を7.0以下に調整してなる多塩基酸型バイオサー
フアクタント系乳化組成物。
1 In the oil phase component, 4,5-dicarboxy-4-pentadecanolide (spicrisporic acid), 4,5
- salt of dicarboxy-4-pentadecanolide,
The lactone ring of 4,5-dicarboxy-4-pentadecanolide was opened to form a 3-hydroxy-1,3,
A polybasic acid type biosurfactant emulsion composition prepared by adding at least one of the four components of 4-tetradecanetricarboxylic acid or a salt thereof and adjusting the pH value to 7.0 or less.
JP60170627A 1985-07-31 1985-07-31 Polybasic acid type bio-surfactant emulsified composition Granted JPS6230546A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60170627A JPS6230546A (en) 1985-07-31 1985-07-31 Polybasic acid type bio-surfactant emulsified composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60170627A JPS6230546A (en) 1985-07-31 1985-07-31 Polybasic acid type bio-surfactant emulsified composition

Publications (2)

Publication Number Publication Date
JPS6230546A JPS6230546A (en) 1987-02-09
JPH0510969B2 true JPH0510969B2 (en) 1993-02-12

Family

ID=15908375

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60170627A Granted JPS6230546A (en) 1985-07-31 1985-07-31 Polybasic acid type bio-surfactant emulsified composition

Country Status (1)

Country Link
JP (1) JPS6230546A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0733323B2 (en) * 1986-10-15 1995-04-12 東洋ビユ−テイ株式会社 External skin preparation
FR3012959B1 (en) * 2013-11-08 2016-01-01 Oreal COSMETIC COMPOSITION COMPRISING SPICULISPORIC ACID AND AT LEAST ONE SURFACTANT
FR3012958B1 (en) * 2013-11-08 2016-01-01 Oreal COSMETIC COMPOSITIONS COMPRISING SPICULISPORIC ACID AND AT LEAST ONE SURFACTANT SULFATE AND / OR SULFONATE
JP2021054719A (en) * 2018-01-10 2021-04-08 株式会社カネカ Emulsified composition obtained by effectively dispersing powder
JP7212634B2 (en) * 2018-01-12 2023-01-25 株式会社カネカ GEL COMPOSITION AND METHOD FOR MANUFACTURING SAME

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6031821A (en) * 1983-08-01 1985-02-18 Agency Of Ind Science & Technol Stabilizing agent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6031821A (en) * 1983-08-01 1985-02-18 Agency Of Ind Science & Technol Stabilizing agent

Also Published As

Publication number Publication date
JPS6230546A (en) 1987-02-09

Similar Documents

Publication Publication Date Title
US4174296A (en) Water soluble lecithin composition
CN1160046C (en) Body cleansing agent
KR100417365B1 (en) Surfactant composition
KR950003411B1 (en) Gel-like emulsion and o/w emulsions obtained from the gel-like emulsion
JPH026731B2 (en)
US5362418A (en) Gel-like emulsion and O/W emulsion obtained from the gel-like emulsion
JPS6341411A (en) Dermatic agent for external use
JPH0510969B2 (en)
EP0062352B1 (en) Soap composition
KR102163156B1 (en) Preparation method of cleansing cosmetic composition using eutectic point and the compostion
JPS58128311A (en) Solubilizer resistant to temperature change and solubilization
US2086479A (en) Stable emulsion and method of producing the same
EP0273619B1 (en) Cosmetic composition
JP2003336091A (en) Detergent composition
JP2004174494A (en) Aqueous emusifier wax gel
JP3985475B2 (en) Microemulsion containing succinic acid monoglyceride salt and cosmetic and food containing the same
JPS588545A (en) Emulsifier and emulsified cosmetic
JPS61129038A (en) Emulsifier composition
JPH08505900A (en) Concentrated surfactant composition
CN111629706A (en) Method for preparing transparent nanoemulsion containing bay oil
JPH0563219B2 (en)
JP6265550B2 (en) Ascorbic acid derivative composition and method for producing the same, ascorbic acid derivative solution, and external preparation for skin
JPH0881391A (en) Solubilizing agent and solubilizing composition
JP2724852B2 (en) Microemulsion
JP2583775B2 (en) Oil-in-water emulsion cosmetic

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term